Originally published by Arnold & Itkin.
Our attorneys recently won a $70 million verdict against Johnson &
Johnson subsidiary Janssen Pharmaceuticals over damages caused by the
drug Risperdal, an infamous antipsychotic. The
$70 million verdict was the largest verdict to date. After Arnold & Itkin won the historic victory against Janssen, the
drug maker immediately filed post-trial motions in order to overturn the decision.
When we heard about the post-trial motions, Attorney Jason Itkin was not
worried about their success. He commented that: “We believe that
the issues Johnson & Johnson complains about amount to sour grapes.
We had a very smart, attentive jury. The jury considered the evidence
and reached their verdict. I doubt such a motion would be filed by the
drug company if they had achieved a better result.”
As it turns out, we were right to dismiss Janssen’s efforts.
Judge Paula Patrick, the judge who oversaw our case, issued an order denying
Janssen’s motions asking for a new trial or a new judgement. We
at Arnold & Itkin are pleased that the Judge upheld the jury’s
decision and that the decision brings our client one step closer to achieving
justice in this case.
At Arnold & Itkin, we understand the significance of our case in light
of the thousands of cases currently awaiting trial. We hope our case result
will help encourage other plaintiffs to continue to fight for justice.
from Texas Bar Today http://ift.tt/2a9zqia
via Abogado Aly Website